Biotechs Soar After Big Trump Drug Price Speech- Mid-Caps Should Outperform
May 14, 2018 at 15:11 PM EDT
Biotechs soared Friday immediately after Trump’s much-anticipated new drug plan speech which was going to address high drug prices and potentially bring more government intervention.
